Ganymed ag mainz
advisor in the life science area, located in Zurich, Switzerland. Ganymed, august 21, 2008, Mainz, ganymed, pharmaceuticals, aG today announced the sale of a majority of the company shares to ATS. The company was founded in 2001 and is schley bochum öffnungszeiten pfingsten based. Ganymed is a privately held company located. Recent Private Companies Transactions, type, date, target. Nextech Venture is substantially stepping up its investment activity in the oncology field). About Nextech Venture Nextech Venture Ltd. Where is your business located? No transactions available in the past 12 months. With a world leading expertise in pinpointing highly specific proprietary targets, ganymed is building a growing sustainable pipeline of antibody therapeutics targeting solid cancers with high medical need and large market potential. "We are very proud of what has been achieved with the syndicate of early investors' financial, strategic and operational support together with the.
Select State / HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth IslandSouth CarolinaSouth.C.West ColumbiaManitobaNew BrunswickNewfoundlandNova ScotiaOntarioPrince Edward IslandQuebecSaskatchewanYukon Where is your business located? The shares that have been sold to ATS were formerly those. Ganymed, pharmaceuticals operates in, mainz, Germany. The Company researches and produces therapeutic drugs for the treatment of solid cancers. "Together with ATS, ganymed is pursuing a long-term development strategy and a substantial expansion of our antibody pipeline to include a broad portfolio of development candidates for the treatment of solid cancers said founder and CSO. This is in addition. Ganymed is at the same time expanding its pipeline to include five further antibody projects in development for breast, colorectal, lung, pancreatic and prostate cancers, as well as for other solid tumors with high medical need and large market potential.
Please describe your company. As of December 20, 2016, Ganymed, pharmaceuticals, aG operates as a subsidiary of Astellas Pharma Inc. Ganymed has brought together arguably the strongest and most dynamic scientific team for translational medicine. For further information please visit www.
Ebay kleinanzeigen 3 zimmer wohnung mainz, Mainz bischofsheim kostenlos parken, Drechslerweg mainz,
The oncology fund is supported by a top-class Scientific Advisory Board of oncology experts, chaired by David. Ganymed also has five further antibody projects in development for breast, colorectal, lung, pancreatic and prostate cancers. Ganymed, pharmaceuticals, aG develops pharmaceutical products. The companys pipeline includes imab362, an antibody drug candidate for the treatment of gastroesophageal cancer; imab027, a monoclonal antibody selectively binding to the cell surface protein claudin-6 that is present in a range of cancers, including testicular, ovarian, uterine, and lung cancers; second generation. Germany, founded in 2001, phone:, fax: www. What is your business name? Ganymed, pharmaceuticals, aG operates as a biopharmaceutical company that focuses on the development of therapeutic drugs for the treatment of solid cancers. Beside two early stage venture capital funds focusing on Europe, the Company has just launched the world's first oncology focused fund to support leading oncology companies developing cancer drugs worldwide. Alfred Scheidegger, founding partner of Nextech Venture. About ATS ATS Beteiligungsverwaltung GmbH operates as a "Family Office" for the Strüngmann brothers, offering their know-how and strategic support to selected biotech companies. It also develops Claudetect18.2, a CE marked in vitro diagnostic test to assess the expression levels of claudin-18.2 in gastroesophageal, pancreatic, lung, and other solid tumors. "Over the last year we have been very impressed with.